Multidisciplinary Thoracic Cancers Symposium 
March 16-18, 2017
San Francisco, CA
We are pleased to invite you to attend the 2017 Multidisciplinary Thoracic Cancers Symposium, taking place March 16-18, at the San Francisco Marriott Marquis. The symposium will bring together radiation and medical oncologists, thoracic surgeons and all members of the treatment team in a comprehensive and practical meeting for the entire thoracic cancer community.
Here are a few of the program highlights related to general thoracic surgery:
- A General Session on Screening, Diagnosis and Staging that includes presentations on “Lung Cancer Screening” from Douglas E. Wood, MD and “Mediastinal Staging Approaches: Minimally Invasive to Invasive” from Ara A. Vaporciyan, MD.
- A Keynote on “Personalized Surgical Approaches to Therapy” with Valerie W. Rusch, MD.
- Oral abstracts presenting the latest scientific breakthroughs in thoracic cancer treatment.
- A Plenary Session on Early Stage Thoracic Cancers, with radiation, medical and surgical presentations, including “Surgical Outcomes for Stage 1 Lung Cancer” from Dr. Whyte and an Early Stage Tumor Board.
- A General Session on Locally Advanced Stage III Cancer, with a session by Linda W. Martin, MD, MPH, on “Role of Surgery in Stage III (N2) Disease” and a Locally Advanced Tumor Board.
- A General Session on Practical Guidance in Precision Medicine--Bridging the Gap Between Research and the Clinic.
- Two General Sessions on Advanced Non-small Cell Lung Cancer, with a focus on “Targeted Therapy and Immunotherapy” and presentations on Palliative Care, Quality of Life and Oligometastatic Disease, followed by an Advanced Non-small Cell Lung Cancer Tumor Board.
- A General Session examining other types of thoracic tumors, including Small Cell Lung Cancer, Mesothelioma and Thymic Tumors.
- A final General Session on Immunotherapy in Lung Cancer.
View the full schedule of sessions, presentations and faculty .
We hope you will join us for this important meeting focused on practical relevant data and the most current clinical and translational research—and, be sure to register as an STS Member to receive a discount.
We look forward to welcoming you to San Francisco in March!
Jessica S. Donington, MD & Richard Whyte, MD
2017 Multidisciplinary Thoracic Cancers Symposium Steering Committee